clonidine has been researched along with Hemisensory Neglect in 3 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lerner, AG | 2 |
Finkel, B | 2 |
Oyffe, I | 2 |
Merenzon, I | 1 |
Sigal, M | 2 |
Covey, WC | 1 |
Ignatowski, TA | 1 |
Knight, PR | 1 |
Spengler, RN | 1 |
Gelkopf, M | 1 |
Katz, S | 1 |
Weizman, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Trial of Etanercept (TNF-α Blocker) for Treatment of Blast-Induced Tinnitus[NCT04066348] | Phase 2 | 310 participants (Anticipated) | Interventional | 2022-07-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for clonidine and Hemisensory Neglect
Article | Year |
---|---|
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study.
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Hallucinogens; Humans; Lysergic Acid Diethylamide; Perc | 2000 |
2 other studies available for clonidine and Hemisensory Neglect
Article | Year |
---|---|
Clonidine treatment for hallucinogen persisting perception disorder.
Topics: Adult; Clonidine; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Perceptual Disorders; Sub | 1998 |
Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain; Chronic Disease; Clonidine; | 2000 |